Loading data for IRWD — first visit, this takes a few seconds.
Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS: IRWD
· 实时价格 · USD
4.41
+0.14 (3.28%)
收盘价： Sep 10, 2026, 5:16 PM
股价、关键数字和最新消息，都在这一页。
Ironwood Pharmaceuticals, Inc.（IRWD）股价、分析与数据
暂无数据
| 买价 | 3.74 |
| 市值 | 657M |
| 营收（TTM） | 389M |
| 净利润（TTM） | 130M |
| 0.21 | |
| 0.77 | |
| 5.03 | |
| 2.65 | |
| 市净率（TTM） | -4.06 |
| 市销率（TTM） | 1.69 |
| 财报日期 | Feb 15, 2024 |
| 卖价 | 4.95 |
| 成交量 | 2,427,301 |
| 20日均量 | 2,228,831 |
| 开盘价 | 4.31 |
| 前收盘价 | 4.27 |
| 日内区间 | 4.26 - 4.47 |
| 52周区间 | 1.01 - 5.78 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 IRWD
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional...
公司完整简介财报意外
Ironwood Pharmaceuticals 已于 Aug 6, 2026 发布季度财报：
- 营收为 $113.04M 低于预期 $0, ， 32.62% 同比增长.
- 每股收益为 0.31 超出预期 0.03, ， 121.43% 同比增长.
第 1 页，共 2 页